Want to see HK:2607 full AI Analyst Report?
Shanghai Pharmaceuticals Holding Co (2607) Revenue
Shanghai Pharmaceuticals Holding Co Revenue
Shanghai Pharmaceuticals Holding Co had a revenue of 75.48B in the quarter ending Sep 30, 2026, with 4.98%. This bring the company's revenue in the last twelve months to 290.47B, Increased 0.70%. In the fiscal year ending Dec 31, 2025, Shanghai Pharmaceuticals Holding Co had annual revenue of 283.58B with 3.03% growth.
- Revenue (ttm)
- 290.47B
- Revenue Growth
- 9.12%
- P/S Ratio
- 0.23
- Revenue/Employee
- HKD 5,716,409
- Employees
- 49,608
- Market Cap
- HKD 64.52B
Revenue Chart
Shanghai Pharmaceuticals Holding Co Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 283.58B | 8.33B | 3.03% |
| Dec 31, 2024 | 275.25B | 14.96B | 5.75% |
| Mar 31, 2024 | 260.30B | 28.31B | 12.21% |
| Dec 31, 2022 | 231.98B | 16.16B | 7.49% |
| Dec 31, 2021 | 215.82B | 23.92B | 12.46% |
| Dec 31, 2020 | 191.91B | 5.34B | 2.86% |
| Dec 31, 2019 | 186.57B | 27.48B | 17.27% |
| Dec 31, 2018 | 159.08B | 28.24B | 21.58% |
| Dec 31, 2017 | 130.85B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.